LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
628
via seekingalpha.comMarkets

Gilead Sciences Q3 2026 earnings preview

FROM THE WIRE · SEEKINGALPHA.COM

[Maker Of Coronavirus Trial Drug Remdesivir, Gilead Sciences. Inc., Reports Positive Data Coming From Trials] Justin Sullivan/Getty Images News Gilead Sciences (GILD [https://seekingalpha.com/symbol/GILD]) is scheduled to report third-quarter earnings on Thursday, October 29…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralA large pharma's earnings are expected to decline, relevant for the stock but without a clear surprise signal.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Gilead will report third-quarter results on Thursday, October 29, after market close.
  2. 02Consensus EPS is $2.19, down 11.3% from a year earlier.
  3. 03Revenue is projected at $7.8 billion, up 0.4%.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.